Cite
MLA Citation
Diana Hernández et al.. “A1.26 Establishing cut-off of infliximab levels and anti-infliximab antibodies by commercial elisa in patients with rheumatoid arthritis.” Annals of the rheumatic diseases, vol. 73, 2014, p. A11. http://access.bl.uk/ark:/81055/vdc_100135547543.0x000062